Trump announces trade deal with EU following months of negotiations
Gajendra Sanjay, the President and Chief Operating Officer of Astera Labs , Inc. (NASDAQ:ALAB), a company currently valued at $14.25 billion, has recently sold a significant portion of the company’s common stock. According to a Form 4 filing with the SEC, Sanjay sold shares totaling approximately $31.39 million on February 19, 2025. The shares were sold at prices ranging from $87.83 to $92.35. InvestingPro data shows the stock has surged over 110% in the past six months, despite recent market volatility.
This transaction was part of an automatic sale to cover tax withholding obligations related to the vesting and settlement of restricted stock units previously granted to Sanjay. Following these transactions, Sanjay continues to hold over 2.35 million shares directly, with additional shares held indirectly through estate planning trusts. According to InvestingPro analysis, Astera Labs is expected to turn profitable this year, with analysts forecasting 69% revenue growth. For deeper insights into insider trading patterns and 12 additional ProTips, subscribers can access the comprehensive Pro Research Report.
In other recent news, Astera Labs reported robust financial results for the fourth quarter of 2024, achieving record revenue of $141.1 million, marking a 179% year-over-year increase. The company also posted earnings per share of $0.37, aligning with analysts’ expectations. Looking ahead, Astera Labs provided revenue guidance for the first quarter of 2025 in the range of $151-$155 million, indicating continued growth. Stifel analysts maintained a Buy rating on Astera Labs, with a $150 price target, highlighting the company’s significant revenue growth, which surpassed estimates by 10.2% for the fourth quarter of 2024. Additionally, Needham reaffirmed its Buy rating with a $140 target, noting the strong sales of Astera Labs’ Taurus and Aries product lines. Jefferies also reiterated a Buy rating with an $85 price target, despite concerns about the sustainability of the Trn2 segment’s growth and a softer gross margin mix. These recent developments reflect a positive outlook for Astera Labs, with analysts emphasizing the company’s growth potential and diverse product offerings.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.